Clarus Therapeutics Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/18/2022 | Q2 2022 | -$1.39 | $4.05 M | |||
| 05/16/2022 | Q1 2022 | -$0.40 | -$1.84 | -1.44 | $4.01 M | |
| 03/31/2022 | Q4 2021 | -$2.87 | $6.89 M | |||
| 11/19/2021 | Q3 2021 | -$0.30 | $4.29 M | |||
| 08/13/2021 | Q2 2021 | -$0.83 | $2.78 M | |||
| 05/25/2021 | Q1 2021 | $3.06 | $0 | |||
| 05/06/2021 | Q4 2020 | $0.00 | $0 | |||
| 09/29/2020 | Q3 2020 | $0.25 | $2.22 M |
Clarus Therapeutics Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Clarus Therapeutics Holdings, Inc.'s earnings date?
Clarus Therapeutics Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 18th, 2022 based off last year's report dates.
-
Did Clarus Therapeutics Holdings, Inc. beat their earnings estimates last quarter?
In the previous quarter, Clarus Therapeutics Holdings, Inc. (:CRXT) reported $-0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.05.
-
How can I listen to Clarus Therapeutics Holdings, Inc.'s earnings conference call?
The conference call for Clarus Therapeutics Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Clarus Therapeutics Holdings, Inc.'s conference call transcript?
The conference call transcript for Clarus Therapeutics Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Clarus Therapeutics Holdings, Inc. generate each year?
Clarus Therapeutics Holdings, Inc. (:CRXT) has a recorded annual revenue of $13.96 M.
-
How much profit does Clarus Therapeutics Holdings, Inc. generate each year?
Clarus Therapeutics Holdings, Inc. (:CRXT) has a recorded net income of $13.96 M. Clarus Therapeutics Holdings, Inc. has generated $-2.35 earnings per share over the last four quarters.
-
What is Clarus Therapeutics Holdings, Inc.'s price-to-earnings ratio?
Clarus Therapeutics Holdings, Inc. (:CRXT) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.
